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The National Institute for 
Occupational Safety and 
Health (NIOSH) received 
a management request 
for a health hazard 
evaluation at a nationwide 
retail pharmacy chain. 
The request concerned 
the potential exposure 
of pharmacists to 
needlestick injuries while 
administering vaccines 
in pharmacy locations 
nationwide.
HigHligHts of tHe 
niosH HeAltH 
HAzARd evAluAtion
What NIOSH Did
We reviewed the company’s written policies and procedures  ●
regarding vaccine administration, needlestick injuries, and 
bloodborne pathogens.
We reviewed the company’s needlestick injury reports and  ●
then analyzed the information in them.
We observed work practices and interviewed eight employees  ●
at two pharmacies in October 2011.
What NIOSH Found
The company has comprehensive written policies and  ●
procedures.
Thirty-three needlestick injuries were reported across an 11- ●
year period.
The annual incidence of needlestick injuries ranged from  ●
0–3.62 per 100,000 vaccinations and ranged from 0–5.65 per 
1,000 immunizing pharmacists.
Observed work practices involving sharps were safe at both  ●
pharmacies we visited.
What Managers Can Do
Continue to encourage employees to follow all written work  ●
procedures.
Promote prompt reporting of all needlestick injuries. ●
Make sure that the needlestick injury reports have complete  ●
information.
Ask for additional information about the circumstances of  ●
the injury for these reports.
What Employees Can Do
Continue to follow safe work practices during all clinical  ●
procedures.
Wash your hands before and after every clinical procedure. ●
Dispose of used needles promptly in appropriate sharps  ●
disposal containers.
Promptly report all needlestick injuries. ●
Follow company health and safety policies and procedures. ●
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NIOSH investigators 
examined pharmacists’ 
exposure to needlestick 
injuries in a retail 
pharmacy chain. We 
found 33 reported 
needlestick injuries 
across an 11-year period. 
The company’s written 
policies and procedures 
were comprehensive. 
Work practices relating to 
sharps were safe at both 
pharmacies we visited.
summARy
In February 2011, NIOSH received an HHE request from management 
representatives at a nationwide retail pharmacy chain. The request 
concerned pharmacists’ potential exposure to needlestick injuries 
while administering vaccines in pharmacy locations nationwide. The 
pharmacy chain began offering adult vaccinations in 2000 in select 
locations and had since expanded this service to all locations.
Prior to our visit, we reviewed the company’s written policies and 
procedures regarding vaccine administration, needlestick injuries, 
and bloodborne pathogens. We also analyzed the information in the 
company’s needlestick injury reports. We visited two pharmacies in 
October 2011 where we observed work processes, work practices, and 
workplace conditions. We also interviewed pharmacy employees.
The company’s written policies and work procedures were 
comprehensive. In our review of needlestick injury reports, we 
found 33 reported needlestick injuries over an 11-year period. The 
annual incidence of needlestick injuries ranged from 0–3.62 per 
100,000 vaccinations and ranged from 0–5.65 per 1,000 immunizing 
pharmacists. Work practices relating to sharps were observed to be 
safe at both of the pharmacies we visited.
 
Pharmacists who have the added responsibility of administering 
vaccinations have become an emerging occupational group at risk of 
needlestick injuries. However, the incidence of needlestick injuries 
among employees at this retail pharmacy chain appears to be lower 
than that found in the hospital setting. This may be due to the nature 
of the procedures being performed, which require less manipulation 
(such as phlebotomy or suturing), activation of the safety devices, the 
company’s training programs, and safe work practices.
We recommended that the company continue to encourage 
employees to follow all written work procedures. We recommended 
improvements to the positioning of patients and equipment during 
vaccine administration and health screenings to improve safety. 
We also recommended obtaining additional information on the 
circumstances of the injury for the needlestick injury reports. This 
information may be useful in determining factors contributing to 
these injuries at the pharmacy and in evaluating the safety of devices. 
Employees should continue to use safe work practices during vaccine 
administration and health screenings and should promptly report all 
needlestick injuries.
Keywords: NAICS 446110 (Pharmacies and Drug Stores), 
needlestick injuries, sharps injuries, bloodborne pathogens, 
pharmacy, pharmacists, vaccination
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intRoduCtion
In February 2011, NIOSH received an HHE request from 
management representatives at a nationwide retail pharmacy 
chain. The request involved the potential exposure of pharmacists 
to needlestick injuries from the administration of vaccines across 
pharmacy locations nationwide. The pharmacy chain began 
offering adult vaccinations in 2000 in select locations and had 
expanded this service to all locations.
Prior to our visit, we reviewed the company’s written policies and 
procedures regarding vaccine administration, needlestick injuries, and 
bloodborne pathogens. We also reviewed manufacturer information 
on the injection devices used by pharmacy employees and analyzed 
the information collected by the company in its needlestick injury 
reports. During our on-site evaluation at two locations in October 
2011, we observed work processes, work practices, and workplace 
conditions and interviewed pharmacy employees.
Retail Pharmacy Chain
At the time of our evaluation, the retail pharmacy chain was 
located within a national retail grocery company. The company 
operated approximately 2,500 retail grocery locations and more 
than 800 in-store pharmacies in 25 states.
At the time of our evaluation, vaccinations offered at the 
retail pharmacy chain included the influenza, pneumococcal, 
tetanus/diphtheria/pertussis, hepatitis A, hepatitis B, human 
papillomavirus, herpes zoster, and meningococcal vaccines. 
Vaccinations were offered by appointment or on a walk-in basis at 
the pharmacies or in a clinic setting. As of February 2011, 2,150 
certified immunizing pharmacists were employed at 805 pharmacy 
locations within the company.
Needlestick Injuries and Exposure to 
Bloodborne Pathogens
Needlesticks and other percutaneous injuries pose the greatest 
risk of occupational transmission of bloodborne pathogens 
to healthcare workers [Beltrami et al. 2000; CDC 2001]. The 
bloodborne pathogens of most concern include hepatitis B virus, 
hepatitis C virus, and HIV. More information on these pathogens 
can be found in the Appendix.
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intRoduCtion
  (Continued) In 1991, OSHA issued its bloodborne pathogens standard, requiring employers to maintain a written exposure control plan and adopt 
engineering and work practice controls that would eliminate 
or minimize employee exposure from hazards associated with 
bloodborne pathogens [29 CFR 1910.1030]. The standard was most 
recently revised in 2001. This revision added new requirements 
for employers, including additions to the exposure control plan 
and keeping a sharps injury log. It specifies in greater detail the 
engineering controls, such as safer medical devices, that must be used 
to reduce or eliminate worker exposure [29 CFR 1910.1030].
Most recent estimates have calculated the number of percutaneous 
injuries sustained annually by hospital-based healthcare workers 
to be 384,325 [Panlilio et al. 2004]. About half of these injuries go 
unreported [CDC 1997; EPINet 1999; Osborn et al. 1999]. Data 
has shown that most reported percutaneous injuries are associated 
with hollow-bore needles and that approximately 38% of injuries 
occur during use, and 42% occur after use and before disposal 
[NIOSH 1999]. Most studies have focused on these types of injuries 
in hospital settings while fewer have focused on long-term care 
facilities and outpatient medical and dental settings. Few studies 
have focused on injuries associated with vaccination campaigns 
[Haire and Sharma 1996; Abraham and Middleton 1997], and no 
studies have focused on injuries occurring in retail pharmacies.
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Assessment
The purpose of our evaluation was to determine the incidence of 
needlestick injuries among pharmacy employees from 2000–2011 
and to assess and make recommendations to improve the controls 
in place to reduce the potential for needlestick injuries.
Our evaluation included the following activities: (1) a review of 
the company’s written policies and procedures regarding vaccine 
administration, needlestick injuries, and bloodborne pathogens; 
(2) an analysis of the company’s needlestick injury reports; and (3) 
an on-site evaluation at two pharmacy locations where we observed 
work processes, work practices, and workplace conditions and 
interviewed pharmacy employees.
Review of Company’s Written Policies 
and Procedures
We reviewed the company’s written policies and procedures 
regarding vaccine administration, needlestick injuries, and 
bloodborne pathogens. We determined if these policies met 
the requirements set forth by the OSHA bloodborne pathogens 
standard [29 CFR 1910.1030].
Analysis of the Company’s Needlestick 
Injury Reports
The company’s centralized needlestick injury reports from all 
pharmacy locations were obtained and reviewed. We characterized 
the circumstances surrounding these reported injuries. We calculated 
the annual incidence of percutaneous injuries using two methods: 
(1) by dividing the total number of needlestick injuries reported 
during a given year by the total number of vaccinations administered 
by the company during that same year and (2) by dividing the total 
number of needlestick injuries reported during a given year by the 
total number of immunizing pharmacists employed by the company 
during that same year. Because the focus of our evaluation was on 
the potential exposure of pharmacists to needlestick injuries from 
the administration of vaccines, we excluded injuries involving 
lancet needles in our annual incidence calculations. Although the 
company did not collect information on the purpose for which 
the sharps device was initially used, on the basis of our discussions 
with management representatives and employees, we made the 
assumption that all non-lancet needle related injuries were associated 
with vaccination in our annual incidence calculations.
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On-site Evaluation
The two locations for the site visit were chosen in conjunction with 
management representatives at the company because of the high 
volume of vaccinations administered at both. During the visits in 
October 2011, we met with the staff at both pharmacies to discuss 
the HHE request. We observed work processes, work practices, 
and workplace conditions particularly associated with vaccine 
administration and other clinical procedures. We conducted semi-
structured interviews with all employees working at both pharmacies 
on the dates of the visit. We discussed their work history and 
exposures as well as other health and workplace concerns.
Assessment
   (Continued)
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Results
Review of Company’s Written Policies 
and Procedures
The company’s bloodborne pathogens exposure control plan 
was comprehensive and contained all of the required elements 
according to the OSHA bloodborne pathogens standard [29 
CFR 1910.1030]. These required elements include an exposure 
determination, methods of compliance, hepatitis B vaccination, 
post-exposure evaluation and follow-up, communication of hazards 
to employees, and recordkeeping [29 CFR 1910.1030]. At the time 
of our evaluation, the exposure control plan was accessible to all 
employees through the company’s intranet.
Pharmacy employees identified as being at risk for occupational 
exposure to blood or other potentially infectious materials included 
pharmacists giving vaccinations or performing a laboratory test 
or an education session and pharmacy technicians performing 
laboratory tests. All company employees at risk of exposure to 
bloodborne pathogens were encouraged to receive the hepatitis B 
vaccination, which was provided at no charge to them. Employees 
declining hepatitis B vaccination must sign a waiver.
Injured employees were instructed to contact the clinical programs 
department immediately after the injury. The facility/store director 
was required to complete the exposure incident report within 48 
hours and the needlestick injury report form within 72 hours. 
Copies were kept at the facility/store and in the clinical programs 
department. Injured employees were required to visit the designated 
medical provider within 48 hours of the incident for appropriate 
evaluation. The clinical programs department contacted the source 
individual and requested that he or she visit the designated facility 
to get blood tests for hepatitis B, hepatitis C, and HIV.
The company’s vaccine administration protocol stated that 
employees should never bend, break, or recap needles; remove 
needles from disposable syringes; or overfill, reach into, open, 
empty, or reuse a sharps container. Employees were instructed to 
dispose of all sharps items immediately in marked containers.
At the time of our evaluation, the company’s immunizing 
pharmacists were required to be specially trained by attending 
an immunization certificate program. The company offered 
the American Pharmacists Association’s Pharmacy-Based 
Immunization Delivery, a national certificate program for 
pharmacists. Training consisted of self-study followed by a live 
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training seminar. Once these two modules are complete, the 
pharmacist attends an immunization orientation. We reviewed 
the presentation slides for this orientation and found that they 
included information on bloodborne pathogens, the needlestick 
protocol, and use of the retractable safety syringes. The orientation 
also included hands-on practice.
The company’s needlestick injury reporting form contained all of the 
information required by the OSHA bloodborne pathogens standard 
[29 CFR 1910.1030]. This information included the type and brand 
of device involved in the incident, the work area where the exposure 
occurred, and an explanation of how the incident occurred.
Analysis of the Company’s Needlestick 
Injury Reports
Of the 34 injuries reported to the company’s clinical program 
department from 2000–2011, only 33 were actual sharps or 
needlestick injuries. The other report was about a splash rather 
than a needlestick injury.
The 33 total needlestick injuries were reported by 31 different 
pharmacy locations. Two injuries did not have a pharmacy location 
reported. Seventeen (52%) injuries occurred in front of the 
pharmacy, 10 (30%) in the pharmacy, 3 (9%) in flu clinic, 1 (3%) 
in the pharmacy waiting area, 1 (3%) by the consultation window, 
and 1 (3%) in a non-pharmacy location.
Of the 33 needlestick injuries, 24 (73%) occurred from September 
through January, the period during which influenza vaccines are 
commonly administered; 12 (36%) occurred in the month of 
October. Eight injuries (24%) occurred between midnight and noon, 
while the other 25 (76%) occurred between noon and midnight.
Five (15%) injuries occurred with a lancet needle, while 28 (85%) 
injuries occurred with a syringe needle. Of these 28 injuries, the 
VanishPoint® syringe was used in 7 injuries, the BD SafetyGlide™ 
needle was used in 12 injuries, the BD PrecisionGlide™ needle 
was used in 1 injury, and the BD Safety-Lok™ syringe was used 
in 1 injury. The type of needle was not reported in seven injuries. 
A finger was the injured body part in 30 cases, and the palm in 1 
case. The injured body part was not recorded in 2 cases.
Results
  (Continued)
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Results
  (Continued)
Table 1. Explanation of how the needlestick injuries occurred as contained in the company’s needlestick 
injury reports
Explanation* No. (%) Injuries
After use and before disposal of sharp 19 (58)
During use of sharp 6 (18)
While putting sharp into disposal container 5 (15)
Disassembling 2 (6)
Sharp left, inappropriate place 2 (6)
Other† 4 (12)
*Employees could choose more than one explanation of how the incident occurred.
†Other explanations included “while activating safety device,” “taking bag from patient,” “glove got caught in  
safety glide and accidentally got stuck,” “lancet fell on floor, happened while picking it up.”
The company’s sharps injury report form contained check boxes 
for an explanation of how the injury occurred. These explanations 
are displayed in Table 1. Most commonly, the injury was reported 
after use and before disposal of the sharp (58% of injuries). 
Additional details of the circumstances surrounding these injuries, 
such as for what purpose the sharp item was originally used, were 
lacking from the reports.
Numbers of needlestick injuries ranged from 0–14 per year (Table 
2). The years 2000–2001 and 2004–2007 had no needlestick 
injuries reported, while 2010 was the year of the highest number 
of needlestick injuries at 14. We excluded the 5 needlestick injuries 
associated with lancet needles from annual incidence calculations. 
The annual incidence of needlestick injuries ranged from 0–3.62 
per 100,000 vaccinations and ranged from 0–5.65 per 1,000 
immunizing pharmacists (Table 2 and Figure 1). The year 2010 
had the highest incidence at 3.62 needlestick injuries per 100,000 
vaccinations and 5.65 per 1,000 immunizing pharmacists.
On-site Evaluation
At the time of our visit, the first pharmacy had 14 employees, 
including 3 pharmacists, and the second pharmacy had 18 
employees, including 3 pharmacists. All pharmacists administered 
vaccination as part of their responsibilities. Both pharmacies had 
extended hours of operation during the week and regular hours 
during the weekends. The first pharmacy had administered 341 
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Results
  (Continued)
Figure 1. The annual number of needlestick injuries per 100,000 vaccinations.
*2011 data as of November 3, 2011
Table 2. Annual numbers of needlestick injuries, administered vaccinations, and immunizing pharmacists
Year No. needlestick injuries
No. 
administered 
vaccinations
Annual 
incidence 
per 100,000 
vaccinations 
No. immunizing 
pharmacists
Annual 
incidence 
per 1,000 
immunizing 
pharmacists
2000 0     9,900 0        67 0
2001 0   38,000 0      120 0
2002 1   55,685 1.80      270 3.70
2003 1 156,000  0.64     400 2.50
2004 0   42,000 0     540 0
2005 0 225,000 0     731 0
2006 0 129,965 0    538 0
2007 0 146,525 0     821 0
2008 2 232,050 0.86 1,043 1.92
2009 6 391,850 1.28* 1,450 3.45*
2010 14 358,800 3.62† 2,300 5.65†
2011‡ 9 286,383 2.10§ 2,164 2.77§
*One injury was excluded from the 2009 incidence calculation because it was associated with a lancet needle.
†One injury was excluded from the 2010 incidence calculation because it was associated with a lancet needle.
‡2011 data as of November 3, 2011
§Three injuries were excluded from the 2011 incidence calculation because they were associated with a 
lancet needle.
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vaccinations, including 286 influenza vaccinations, from February 
27, 2011, (the start of the company’s fiscal year) through October 
21, 2011. The second pharmacy had administered 897 vaccinations, 
including 790 influenza vaccinations, over the same period. As 
of October 2011 neither pharmacy had reported any needlestick 
injuries since 2002.
Confidential Medical Interviews
We interviewed all four pharmacy employees working at each 
pharmacy on the dates of the visits. These 8 employees included 
3 pharmacists and 5 pharmacy technicians. Only the three 
pharmacists reported administering vaccinations, and all were 
certified by the American Pharmaceutical Association to provide 
immunizations. All three reported completing the American 
Pharmaceutical Association Pharmacy Based Immunization 
Delivery training program and internal company training. All three 
estimated administering vaccines 2–4 years, and all three estimated 
that they had given more than 350 influenza vaccinations during 
the calendar year 2011. Four of the five pharmacy technicians 
reported that they did not come into contact with sharps items 
during their job; the other one performed fingersticks as part of 
her job.
The four pharmacy employees who came into contact with sharps 
items reported never recapping used needles, and all reported they 
always disposed of used needles promptly in appropriate sharps 
disposal containers. None of the eight interviewed employees 
reported ever experiencing a needlestick injury, and none had any 
health concerns related to their work.
Observation of Procedures
During the visit, we observed the following procedures at both 
pharmacies: 11 influenza vaccinations, 2 zoster vaccinations, and 2 
health screenings. For all 13 vaccination procedures, the pharmacy 
employees drew up the syringe and placed all necessary supplies 
in a plastic bin before administering the vaccine. Sharps disposal 
containers were portable. In the first pharmacy, the sharps disposal 
container was also placed in a larger plastic bin that contained 
the other supplies. The sharps disposal container was placed 
conveniently next to the employee for immediate disposal of the 
needle in all but one instance.
Results
  (Continued)
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During 9 vaccination procedures, the pharmacy employees sat 
in a chair perpendicular to the patient’s chair. However, during 
the other 4 vaccination procedures, the vaccinator either stood 
or squatted by the patient’s chair. During 2 of the vaccination 
procedures, the patient was seated in a chair that had wheels.
We observed hand hygiene before administering the vaccine during 
6 of 13 procedures and after administering the vaccine during 
the same 6 procedures. During all 13 procedures, the pharmacy 
employees wore gloves while administering the vaccine, and they 
also activated the safety syringe while the needle was still in the 
patient’s arm (Figure 2). The pharmacies used the VanishPoint® 
syringe, which has a safety device that automatically and instantly 
retracts the needle from the patient into the barrel of the syringe 
when the injection is complete. No recapping of used needles was 
observed. The used syringe was promptly placed in the sharps 
disposal container during 11 procedures. During the other 2 
procedures, the used syringe was placed first in the plastic bin and 
then transferred to the sharps disposal container shortly thereafter.
The health screenings consisted of a blood pressure check and 
a fingerstick for basic laboratory work. During both observed 
screenings, all of the necessary supplies were placed on the 
workspace. Sharps disposal containers were appropriately placed. 
In one screening, the employee stood next to the patient, who 
was seated in a chair with wheels. The employee practiced hand 
hygiene before the fingerstick one out of the two times, wore gloves 
during the fingerstick both times, and practiced hand hygiene after 
the fingerstick both times. During the fingerstick, the safety device 
was activated, and the used lancet needle was promptly placed in 
the sharps disposal container in both instances.
Results
  (Continued)
Figure 2. A pharmacist administering 
the influenza vaccine to a patient. 
She can be seen activating the 
retraction mechanism of the 
introducer needle while the needle is 
still in the patient’s arm.
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disCussion
An increasing proportion of influenza vaccinations are taking 
place in nonmedical or nonclinical settings. During the 1998–
1999 influenza season, 5% of adults reported being vaccinated 
in stores (supermarket or drug store) [Singleton et al. 2005]. 
At that time, only 22 states allowed pharmacists to administer 
influenza vaccinations to adults. By June 2009, all 50 states 
allowed pharmacists to administer influenza vaccinations (under 
prescribing protocols or prescription) to adults [APHA 2009]. For 
the 2010–2011 influenza season, 18.4% of adults received the 
influenza vaccination at stores (supermarket or drug store), which 
was the second most common place of vaccination after a doctor’s 
office [CDC 2011].
To date, no studies have examined needlestick injuries occurring 
in a retail pharmacy setting, and few studies have examined 
needlestick injuries associated with vaccination. Haire and Sharma 
surveyed 28 nurses and 26 physicians during a measles and rubella 
immunization campaign in Britain in 1994 [Haire and Sharma 
1996]. They found that two nurses and three physicians reported 
sustaining a contaminated needlestick injury, though only two 
reported the injury.
In another study, Abraham and Middleton reported that 6 
contaminated needlestick injuries were reported during a measles 
mass vaccination campaign in Canada in 1996 [Abraham and 
Middleton 1997]. This campaign had 63 nurses immunize 112,727 
children at 238 schools, and the needlestick injury rate was 
calculated to be 1 needlestick injury per 18,788 vaccinations, or 
5.32 needlestick injuries per 100,000 vaccinations. Circumstances 
leading to the injuries included technical factors, human factors, 
and disposal issues. These numbers are higher than those found 
in our evaluation, where we found a maximum of 3.62 needlestick 
injuries per 100,000 vaccinations in 2010, the year with the highest 
annual incidence.
Our range of 0–5.65 needlestick injuries per 1,000 immunizing 
pharmacists is also lower than the range of 23–103 needlestick 
injuries per 1,000 healthcare workers calculated by Lee et al. 
in five studies of reports in hospital settings [Linnemann et al. 
1991; Haiduven et al. 1992; Longbottom et al. 1993; Jackson et 
al. 1994; Hatcher 2002; Lee et. al 2005]. This discrepancy can be 
explained by a few potential factors. First, the risk of needlestick 
injuries from vaccinations compared to other procedures 
involving sharps items such as phlebotomy and suturing may be 
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lower because of the nature of the procedure that requires less 
manipulation. Second, all of the syringes and lancet needles used 
by the company’s immunizing pharmacists had safety devices, and 
this likely also lowers the risk. Third, the pharmacists we observed 
during our visit all adhered to safe practices when administering 
vaccinations and obtaining fingersticks (i.e., activation of the safety 
device and optimal placement of sharps disposal containers), and 
the company’s training programs were comprehensive.
Our evaluation was subject to some limitations. First, we analyzed 
33 reports of needlestick injuries recorded in the company’s 
national sharps injury reports. The incidence of needlestick 
injuries reported here is likely an underestimation of the actual 
incidence of these injuries among employees for two reasons. 
Studies have shown that underreporting of percutaneous injuries 
in healthcare workers occurs widely; calculations have estimated a 
43.4% underreporting rate [Panlilio et al. 2004]. Also, it is possible 
that not all incidents at the individual pharmacy locations were 
reported to the national program office. Second, some needlestick 
injury reports had missing information, including type of device, 
pharmacy location, and injured body part. Third, we were unable to 
obtain the laboratory testing results of the source patients involved 
in the needlestick injury. Thus, we are unable to determine the 
actual exposure of the injured employees to hepatitis B, hepatitis 
C, or HIV. Fourth, we had limited information on the injured 
employee so were not able to determine work factors associated 
with an injury. Also, because the company did not collect the job 
titles of affected employees on the needlestick injury report form, 
we were unable to ascertain the number of injuries that occurred 
among pharmacists and pharmacy technicians. However, only 
pharmacists are certified to administer vaccinations, and this 
makes it less likely that needlestick injuries associated with vaccine 
administration occurred among pharmacy technicians. Finally, we 
observed vaccinations and health screenings at only two of the over 
800 pharmacy locations. Thus, our observations are unlikely to be 
representative of all pharmacy employees at all locations.
disCussion
   (Continued)
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ConClusions
Pharmacists who have the added responsibility of administering 
vaccinations have become an emerging occupational group 
at risk of needlestick injuries. In our retrospective review of 
reports of needlestick injuries of a large retail pharmacy chain, 
we found 33 reported needlestick injuries across an 11-year 
period. The annual incidence of needlestick injuries ranged 
from 0–3.62 per 100,000 vaccinations and ranged from 0–5.65 
per 1,000 immunizing pharmacists. These rates appear to be 
lower than those found in the hospital setting. Work practices 
relating to sharps items were observed to be safe at both 
locations of our visit. Though needlestick injuries occur in this 
setting, the pharmacy employees appear to be at relatively low 
risk for needlestick injuries during administration of vaccines 
mainly because of the nature of the procedures that require less 
manipulation, the activation of the safety devices, the company’s 
training programs, and safe work practices.
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ReCommendAtions 
On the basis of the findings of the HHE, we offer some additional 
recommendations to further protect the health and safety of 
pharmacy employees with regard to bloodborne pathogens. We 
encourage the company to use a labor-management health and 
safety committee or working group to discuss the recommendations 
in this report and develop an action plan. Those involved in 
the work can best set priorities and assess the feasibility of our 
recommendations for the specific situation at the company.
More comprehensive recommendations, such as those 
regarding a culture of safety, procedures for reporting and 
examining needlestick injuries, selection of devices, and 
training of employees, can be found in CDC’s “Workbook 
for Designing, Implementing and Evaluating a Sharps Injury 
Prevention Program” at http://www.cdc.gov/sharpssafety/pdf/
sharpsworkbook_2008.pdf [CDC 2008].
Practice hand hygiene before and after giving an injection or 1. 
performing a fingerstick. Hand hygiene can consist of hand 
washing or antiseptic hand rub.
Position the patient in a chair without wheels for vaccine 2. 
administration and health screenings. Pharmacy employees 
should also be seated in a chair perpendicular to the 
patient. A table or other flat surface on which to lay 
supplies and the sharps disposal container should be 
within reach of the pharmacist.
Dispose of used needles promptly in appropriate sharps 3. 
disposal containers. Ensure that these containers are placed 
in a location convenient to the pharmacist for immediate 
disposal. Consider placing the sharps disposal container 
along with the necessary supplies in a larger bin, as we 
observed at one location.
Encourage employees to report all needlestick injuries 4. 
immediately. Emphasize the importance of timely medical 
evaluation and treatment, if indicated.
Ensure that each needlestick injury report contains all of the 5. 
information required by the OSHA bloodborne pathogens 
standard [29 CFR 1910.1030]. This information includes the 
type and brand of device involved in the incident, the work 
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ReCommendAtions  
(Continued) area where the exposure occurred, and an explanation of how the incident occurred. Each submitted report 
should be checked for completeness, and missing or 
incomplete responses should be addressed. Consider 
listing the possible devices that employees use during 
their work and asking injured employees to check 
the device used instead of having them write in this 
information. This change may facilitate more accurate 
reporting about the device.
Consider obtaining additional information in the 6. 
sharps injury reports to include information about 
whether or not the device’s protective mechanism 
had been activated and whether or not the sharps 
item penetrated gloves. This information will give 
insights into employee compliance with activation 
of the device protective mechanisms and glove use. 
Consider obtaining information on the job title of 
the affected employee, the purpose for which the 
sharp item was originally used, if it was contaminated 
or uncontaminated, and if blood was present on the 
device if contaminated. This information will also help 
in characterizing the circumstances of these injuries. 
In addition, consider asking injured employees to give 
their opinions on whether any engineering controls or 
administrative or work practices could have prevented 
the injury. The forms in CDC’s “Workbook for 
Designing, Implementing and Evaluating a Sharps 
Injury Prevention Program” and from the International 
Healthcare Worker Safety Center can be used as guides 
for information to collect and can be adapted to the 
pharmacy setting [IHWSC 2001; CDC 2008].
Send at least annual reminders to individual pharmacy 7. 
locations to send all local needlestick injury reports 
and exposure incident reports to the clinical programs 
department. It is important to have an accurate central 
location for these records.
Review the needlestick injury reports at the local and 8. 
corporate levels at least annually to determine which 
factors contribute to these injuries at the pharmacy 
and gain information that may be helpful in evaluating 
devices.
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Human Immunodeficiency Virus
HIV, also known as the human immunodeficiency virus, is the virus that can lead to acquired immune 
deficiency syndrome, or AIDS. HIV attacks part of the body’s immune system by destroying specific blood 
cells, called CD4+ T cells, which are crucial to helping the body fight diseases. Each year, approximately 
50,000 U.S. residents become infected with HIV [CDC 2011a]. In 2008, an estimated 1,178,350 persons 
were living with HIV, including 236,400 (20.1%) whose infection was undiagnosed [CDC 2011a]. Through 
December 2001, 57 cases of occupational HIV transmission to healthcare workers in the United States 
were documented, and no confirmed cases have been reported since 1999 [Do et al. 2003; CDC 2011b]. 
No cases have been documented in pharmacists [Do et al. 2003]. The average risk for HIV transmission 
after a percutaneous exposure to HIV-infected blood has been estimated to be approximately 0.3% 
[Gerberding 1994; Bell et. al 1997; Ippolito et al. 1999].
Hepatitis B
Hepatitis B is a contagious liver disease that results from infection with the hepatitis B virus. It can range 
in severity from a mild illness lasting a few weeks to a serious, lifelong illness. Effective hepatitis B vaccines 
have been available in the United States since 1981, and since then, the incidence of acute hepatitis B has 
declined. The estimated incidence of hepatitis B infection was 38,000 in 2009, but an estimated 700,000–
1.4 million persons are living with chronic hepatitis B infection [CDC 2008; CDC 2011c; Ioannou et al. 
2011]. The rate of hepatitis B transmission to susceptible (or non-immunized) healthcare workers ranges 
from 6%–30% after a single needlestick exposure from a hepatitis B infected patient [CDC 1997].
Hepatitis C
Hepatitis C is a contagious liver disease that results from infection with the hepatitis C virus. It can range in 
severity from a mild illness lasting a few weeks to a serious, lifelong illness. It more commonly causes chronic 
infection than hepatitis B. An estimated 2.7–3.9 million persons are chronically infected with hepatitis C 
[Armstrong et al. 2006; CDC 2011c]. The number of acute hepatitis C cases has declined to an estimated 
16,000 cases in the United States. The average rate of hepatitis C transmission averages 1.8% for healthcare 
workers exposed to hepatitis C through a needlestick or percutaneous injury [Alter 1997; CDC 1998].
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